Unraveling Long COVID: Key Gene Discoveries

Long COVID: COVID-19 has left a lasting impact on millions, with many continuing to suffer long after the acute phase of the infection. This condition, known as long COVID, presents a range of persistent symptoms that can significantly affect the quality of life. Understanding the underlying causes and mechanisms of long COVID is crucial for developing effective treatments and interventions.


Long COVID: Key Gene Discoveries
Differential gene expression in LC and non-LC patients. (a) Heatmap of day 14 differential gene expression, modified from Heatmapper. (b) Heatmap of day 14 differential gene expression based on WHO criteria, modified from Heatmapper. (c) Heatmap of day 14 differential gene expression in LC patients experiencing brain fog compared to non-LC patients. (d) Volcano plot of upregulated genes.

What is Long COVID?
Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), affects an estimated 10-40% of individuals who have recovered from the initial infection. Symptoms can include fatigue, brain fog, chronic cough, chest pain, and more. Despite its prevalence, the exact causes and mechanisms behind long COVID remain unclear.
 
The Study
A recent study by researchers from York University-Canada, University Health Network, Toronto-Canada, University of Toronto-Canada, Sunnybrook Research Institute-Canada and Michael Garron Hospital-Canada aimed to uncover the biological factors contributing to long COVID by examining gene expression in the upper respiratory tract of patients. The study team focused on individuals who had recovered from the acute phase of COVID-19 and compared those who developed long COVID with those who did not.
 
Methods
The researchers analyzed samples from two outpatient trials conducted in Toronto, Canada, between 2020 and 2022. Participants included symptomatic COVID-19 patients aged 18-70. RNA sequencing was performed on samples collected at the end of the acute phase (day 14) and during the convalescent phase (day 90 or later).
 
Key Findings
-Gene Expression Differences: The study identified 26 upregulated genes in patients who developed long COVID. These genes were involved in various pathways, including immune response, neurotransmission, and inflammation. Examples of these genes include:

-YWHAE: This gene ensures neuronal survival and is targeted by SARS-CoV-2. Its abnormal expression in long COVID patients may lead to early neuronal dysfunction and cognitive issues.
 
-CPB2: Carboxypeptidase B2 is involved in inhibiting fibrinolysis, a process that prevents blood clots from breaking down. Increased levels of CPB2 could contribute to the blood clotting issues observed in long COVID patients.
 
-SLC6A2: This gene is re lated to neurotransmitter transport. Dysregulation in this gene can affect the nervous system, potentially explaining symptoms like brain fog and fatigue.
 
-KLK4: Kallikrein-related peptidase 4 is involved in various physiological processes, including inflammation and tissue repair. Its upregulation may indicate ongoing inflammatory processes in long COVID patients.
 
-RPS6KA1: Ribosomal protein S6 kinase A1 is involved in cell growth and survival. Its dysregulation can impact how cells respond to stress and infection, potentially playing a role in long COVID symptoms.
 
-LCE2C: Late cornified envelope 2C is associated with skin barrier function and immune response. Its upregulation might indicate a heightened state of immune activation in long COVID patients.
 
-ITGA2B: Integrin subunit alpha 2b is crucial for platelet activation and blood coagulation. Increased expression of this gene can contribute to the blood clotting issues seen in long COVID.
 
-Viral Load: Patients with long COVID had a significantly higher viral load and slower viral clearance compared to those without long COVID. This suggests a prolonged immune response and persistent infection in long COVID patients.
 
-Dysregulated Pathways: Key pathways affected in long COVID patients included the complement and fibrinolysis pathways, which are related to the body's immune response and blood clotting processes. Additionally, genes involved in neurotransmission were found to be dysregulated, potentially explaining symptoms like brain fog and fatigue.
 
Understanding the Immune Response
The immune system plays a crucial role in fighting infections, but in long COVID patients, it appears to remain active for an extended period. This prolonged immune response can lead to chronic inflammation and other complications. The study found that the complement pathway, part of the immune system that helps clear pathogens, was more active in long COVID patients. This overactivity could contribute to ongoing inflammation and tissue damage.
 
Neurotransmission and Long COVID
Many long COVID patients report cognitive symptoms such as brain fog and memory problems. The study identified dysregulated genes related to neurotransmission, the process by which nerve cells communicate. For instance, the gene YWHAE, which ensures neuronal survival and is targeted by SARS-CoV-2, was upregulated in long COVID patients. This abnormal gene expression may lead to early neuronal dysfunction and cognitive issues.
 
Implications for Treatment
Understanding these gene expression patterns and pathways offers potential for early intervention and treatment. By identifying biomarkers associated with long COVID, healthcare providers could potentially diagnose and treat the condition earlier, improving patient outcomes.
 
Future Research
While this study provides valuable insights, further research is needed to confirm these findings and explore additional biomarkers. Larger studies with more diverse populations and extended follow-up periods will help refine our understanding of long COVID and its underlying mechanisms.
 
Conclusion
Long COVID continues to pose a significant public health challenge, affecting millions worldwide. This study highlights the importance of understanding the biological factors behind long COVID to develop effective treatments and improve patient care. By identifying key gene expression patterns and pathways, researchers have taken an important step towards unraveling the mysteries of long COVID.
 
Final Thoughts
As our knowledge of long COVID grows, so does the potential for targeted therapies and interventions. Continued research and collaboration among scientists, healthcare providers, and patients will be essential in combating this persistent condition and improving the lives of those affected.
 
The study findings were published in the peer reviewed journal: Pathogens.
https://www.mdpi.com/2076-0817/13/6/510
 
For the latest on Long COVID, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/strategies-to-combat-covid-19-linked-brain-amyloids-and-dementia-alzheimer
 
https://www.thailandmedical.news/news/most-long-covid-patients-likely-to-develop-new-onset-psychiatric-disease
 
https://www.thailandmedical.news/news/dutch-study-sheds-light-on-hemoglobin-levels-and-fatigue-in-long-covid
 
https://www.thailandmedical.news/news/tens-therapy-shows-promise-for-long-covid-pain-relief